All News

While working as a stage manager in a theater in Bombay, India, Dinshah Ghadiali began to read about the potential of color therapy to cure disease.

Company granted 180 days of exclusivity under FDA Competitive Generic Therapy approval pathway.

The vaccine has been shown to induce mucosal immunity in the nasal cavity, which may be effective in blocking transmission of SARS-CoV-2.

Pharmacy organizations have produced advisories to guide workflow and optimize services, yet there still exists a gap in further integration of pharmacists into public health and safety initiatives.

The current surge peaked on January 11, 2021, but took just 5 days to decrease by 10%, compared to 22 days following the first peak in April 2020.

SARS-CoV-2 belongs to a family of human coronaviruses, most of which are characterized by increased transmission in cooler, less humid months and decreased transmission in warmer, more humid months.

Pharmacists can play an important role in educating the public about the safety of the Pfizer and Moderna COVID-19 vaccines.

Addressing genomic differences and socioeconomic disparities is essential in order to address the higher incidences and mortality rates for prostate cancer among African American men.

Study findings suggest that enhanced cleaning and disinfecting policies are effective at reducing the spread of COVID-19.

The approval makes adalimumab the only subcutaneous biologic for pediatric patients with ulcerative colitis that can be administered at home.

The FDA has granted a breakthrough therapy designation to tipifarnib for use in patients with recurrent or metastatic HRAS-mutated head and neck squamous cell carcinoma.

In a CDC press briefing, experts said the vaccine’s single-dose approach will enable more mobile units and pop-up events to vaccinate hard-to-reach populations.

Geographic shifts in the HIV epidemic, racial disparities, and the complexities of the medical system all present obstacles to prevention and treatment services.

A global phase 2/3 study of opaganib in patients with severe COVID-19 is set to be expanded, following FDA review of the data from the phase 2 study of the drug and RedHill Biopharma’s receipt of its recommendations.

A more sensitive test capable of detecting heart function issues early in cancer treatment may be beneficial in preventing heart failure.

The FDA could issue an emergency use authorization as soon as this weekend for the single-shot COVID-19 vaccine.

The estimate is based on a new analysis of out-of-pocket costs for influenza-related hospitalizations in 2018 that were paid by people with Medicare Advantage plans, which are Medicare plans run by private insurance companies.

Investigators found significant decreases in heart rate among patients with postural orthostatic tachycardia syndrome who received ivabradine for 1 month.

The FDA has approved the PD-L1 IHC 22C3 pharmDx assay, developed by Agilent Technologies Inc, for expanded use in patients with non–small cell lung cancer.

Researchers in Australia analyzed data from 57 studies with an overall sample size of 587,280 individuals. Approximately 350,000 people in the pool had been infected with COVID-19 from Asia, Europe, and North and South America.

Those whose waking time varies from day to day may find themselves in as much of a foul mood as those who stayed up extra late the night before, or who got up extra early that morning, according to the study authors.

The time to treatment deterioration in pain in chest, dyspnea, and cough was found to be comparable between patients who received lorlatinib and patients who received crizotinib.

Although challenges around COVID-19 vaccine production and delivery have been addressed and improved in recent months, problems have continued in the implementation of a national vaccination program.

The study compared step impairments across the cognitive spectrum, including people with subjective cognitive impairment, Parkinson disease, mild cognitive impairment, Alzheimer disease, Lewy body dementia, and frontotemporal dementia, as well as cognitively healthy controls.

Recreational substance use was associated with 1.5 to 3 times higher odds of heart disease, with stronger associations among young women.

The FDA has granted a fast track designation to the DNA-mediated interleukin-12 immunotherapy GEN-1 for use in the treatment of patients with advanced ovarian cancer.

This is the third approval for Libtayo, following approvals as the first immunotherapy for patients with advanced basal cell carcinoma and as the first systemic treatment for advanced cutaneous squamous cell carcinoma.